Share on StockTwits

Digirad (NASDAQ:DRAD) Director Jeffrey E. Eberwein acquired 10,000 shares of the company’s stock in a transaction dated Thursday, August 21st. The shares were purchased at an average cost of $3.47 per share, with a total value of $34,700.00. Following the transaction, the director now directly owns 40,000 shares in the company, valued at approximately $138,800. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Digirad (NASDAQ:DRAD) traded up 0.28% during mid-day trading on Friday, hitting $3.52. The stock had a trading volume of 115,118 shares. Digirad has a one year low of $2.50 and a one year high of $4.85. The stock’s 50-day moving average is $3.36 and its 200-day moving average is $3.42. The company has a market cap of $65.5 million and a price-to-earnings ratio of 16.64.

Digirad (NASDAQ:DRAD) last issued its quarterly earnings data on Friday, August 1st. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.01. The company had revenue of $14.60 million for the quarter, compared to the consensus estimate of $12.90 million. On average, analysts predict that Digirad will post $0.09 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Monday, August 25th. Stockholders of record on Tuesday, August 12th will be given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 5.70%. The ex-dividend date of this dividend is Friday, August 8th.

Digirad Corporation is the developer and manufacturer of medical diagnostic imaging systems, including solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications.

Receive News & Ratings for Digirad Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad Co and related companies with Analyst Ratings Network's FREE daily email newsletter.